The value we provide to patients and society will ultimately determine the value we bring to our partners. This principle is JEITO’s North Star. During the JEITO Annual General Meeting, I highlighted to our Limited Partners the performance that has emerged from our guiding mission over the past few months. I introduced the significant progress made by our portfolio companies, which have reached key value milestones. This progress reflects Jeito's selectivity in building a diverse portfolio that meets the high demands of the pharmaceutical industry in specific therapeutic areas. Performance is also about JEITO’s sustainability strategy, which focuses on four key priorities: 1. Making an impact on patients 2. Applying high business standards 3. Creating high-quality jobs while fostering diversity and inclusion 4. Taking responsibility for environmental issues This vision is already bearing fruit, and we are confident it will make a significant difference for all our stakeholders. #FasterForThePatient #FurtherWithTheEntrepreneur #JeitoAGM2024 #privateequity #biopharma
NF at her best!
Inspiring!
Managing Director Healthcare at RBC
3wBravo Sabine and impressive progress and success!